Table 5. Costs by Activity – Percentage of Financial Costs for a ‘Non-Start-Up’ MDA Round.
| National Program | MDA Round | Training | Mapping1 | Mobilization/Education | Drug Distribution | Adverse Reaction Monitoring | Surveillance/Lab | Admin. |
| Albendazole+Mectizan | ||||||||
| Burkina Faso | 2 | 9% | 0% | 7% | 45% | 1% | 5% | 33% |
| Ghana | 2 | 11% | 2% | 30% | 13% | 1% | 27 | 16% |
| Tanzania2 | 4 | 20% | <1% | 28% | 40% | 0% | 3% | 8% |
| Albendazole+DEC | ||||||||
| Dominican3 Republic | 2 | 0% | 5% | 89% | 2% | 4% | ||
| Egypt4 | 2 | 4% | 11% | 2% | 47% | 5% | 12% | 19% |
| Haiti3 | 2 | 5% | 25% | 49% | 4% | 12% | 4% | |
| Philippines | 3 | 10% | 10% | 15% | 38% | 6% | 3% | 18% |
| AVERAGE | 10.8 | 4.1 | 16.0 | 45.9 | 2.4 | 9.1 | 14.6 | |
1
Major expenditures for mapping activities predated the years covered by the cost studies.
2
Average of district and central levels.
3
Haiti and the Dominican Republic distributed training costs across the activities.
4
Governorate level.